Dr. Naghma Hashmi (Co-PI), PhD
CBSCR, ICCBS, University of Karachi, Pakistan
2
2
2
N/A
0
8
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Prof. Dr. Muhammad R Shah, PhD
CBSCR, ICCBS, University of Karachi, Pakistan
Shared therapeutic areas:
Worked with same sponsors:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
Pablo Tebas, MD
University of Pennsylvania
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Senior Manager
Takeda
Shared therapeutic areas:
Lorenzo Berra, MD
Massachusetts General Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects
Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet
All 2 trials loaded